Under these circumstances, AMPK acts as a tumour suppressor, and AMPK activators may provide additional protection against tumorigenesis, such as the effect of phenformin in T-ALL [167]. This evidence concerns the gene PRKAA1 and acute lymphoblastic leukemia.